Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387338268> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W4387338268 endingPage "S224" @default.
- W4387338268 startingPage "S223" @default.
- W4387338268 abstract "Plasma level of Human Epididymis protein 4 (HE4) has been shown to be associated with an increased risk of cardiac events in dilated and ischemic cardiomyopathies. The objective of this study was to examine the prognostic value of HE4 in patients undergoing transcatheter aortic valve implantation (TAVI). Three hundred sixty-two patients (mean age: 79.6 ± 8.2 years; 57.3% men) undergoing TAVI for severe aortic stenosis were prospectively enrolled in this study. The cohort was divided into two groups according to the median value of pre-intervention HE4 plasma levels (115 pmol/l). The primary endpoints were: 1) all-cause mortality and 2) rehospitalization for heart failure (HF). Patients with higher HE4 plasma levels were older (81.2 ± 7.8 years vs 78 ± 8.3 years, p< 0.001) and had global more comorbidities (i.e.: diabetes mellitus, chronic heart failure, renal failure, Euroscore II, STS score and left ventricular ejection fraction; all p< 0.05). During a median follow-up of 2.5 (1.9-3.2) years, 34 (9.4%) patients were rehospitalized for HF, and 98 (27.3%) patients died. The 4-year survival rate was significantly lower in patients with higher HE4 plasma levels (44% vs. 71%; p< 0.001). In the multivariable Cox proportional hazard regression model adjusted for diabetes mellitus, chronic heart failure, coronary artery disease, chronic obstructive pulmonary disease, atrial fibrillation, Society of Thoracic Surgeons score, and left ventricular ejection fraction, patients with HE4 >115 pmol/l had a higher risk of all-cause mortality (HR [95%CI]: 3.32 [1.96-5.60], p< 0.001). They also had a 4-year higher rate of rehospitalization for HF (13 vs. 6%; log-rank p-value = 0.015; adjusted HR [95%CI]: 2.1 [1.05-4.47], p=0.01). Elevated HE4 plasma levels are independently associated with a higher risk of all-cause mortality and HF rehospitalization following TAVI. This novel biomarker may be useful to enhance risk stratification and therapeutic decision-making.View Large Image Figure ViewerDownload Hi-res image Download (PPT)" @default.
- W4387338268 created "2023-10-05" @default.
- W4387338268 creator A5014237759 @default.
- W4387338268 creator A5014768387 @default.
- W4387338268 creator A5015577007 @default.
- W4387338268 creator A5028812667 @default.
- W4387338268 creator A5031759179 @default.
- W4387338268 creator A5033615107 @default.
- W4387338268 creator A5038392664 @default.
- W4387338268 creator A5046395462 @default.
- W4387338268 creator A5046485954 @default.
- W4387338268 creator A5052820556 @default.
- W4387338268 creator A5066185558 @default.
- W4387338268 creator A5070728487 @default.
- W4387338268 creator A5081876737 @default.
- W4387338268 creator A5090350974 @default.
- W4387338268 creator A5091205838 @default.
- W4387338268 date "2023-10-01" @default.
- W4387338268 modified "2023-10-17" @default.
- W4387338268 title "PROGNOSTIC VALUE OF HUMAN EPIDIDYMIS PROTEIN 4 FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION" @default.
- W4387338268 doi "https://doi.org/10.1016/j.cjca.2023.06.342" @default.
- W4387338268 hasPublicationYear "2023" @default.
- W4387338268 type Work @default.
- W4387338268 citedByCount "0" @default.
- W4387338268 crossrefType "journal-article" @default.
- W4387338268 hasAuthorship W4387338268A5014237759 @default.
- W4387338268 hasAuthorship W4387338268A5014768387 @default.
- W4387338268 hasAuthorship W4387338268A5015577007 @default.
- W4387338268 hasAuthorship W4387338268A5028812667 @default.
- W4387338268 hasAuthorship W4387338268A5031759179 @default.
- W4387338268 hasAuthorship W4387338268A5033615107 @default.
- W4387338268 hasAuthorship W4387338268A5038392664 @default.
- W4387338268 hasAuthorship W4387338268A5046395462 @default.
- W4387338268 hasAuthorship W4387338268A5046485954 @default.
- W4387338268 hasAuthorship W4387338268A5052820556 @default.
- W4387338268 hasAuthorship W4387338268A5066185558 @default.
- W4387338268 hasAuthorship W4387338268A5070728487 @default.
- W4387338268 hasAuthorship W4387338268A5081876737 @default.
- W4387338268 hasAuthorship W4387338268A5090350974 @default.
- W4387338268 hasAuthorship W4387338268A5091205838 @default.
- W4387338268 hasBestOaLocation W43873382681 @default.
- W4387338268 hasConcept C126322002 @default.
- W4387338268 hasConcept C134018914 @default.
- W4387338268 hasConcept C164705383 @default.
- W4387338268 hasConcept C207103383 @default.
- W4387338268 hasConcept C2778198053 @default.
- W4387338268 hasConcept C2778213512 @default.
- W4387338268 hasConcept C2779161974 @default.
- W4387338268 hasConcept C2780007028 @default.
- W4387338268 hasConcept C2781414266 @default.
- W4387338268 hasConcept C44249647 @default.
- W4387338268 hasConcept C50382708 @default.
- W4387338268 hasConcept C555293320 @default.
- W4387338268 hasConcept C71924100 @default.
- W4387338268 hasConcept C72563966 @default.
- W4387338268 hasConcept C78085059 @default.
- W4387338268 hasConceptScore W4387338268C126322002 @default.
- W4387338268 hasConceptScore W4387338268C134018914 @default.
- W4387338268 hasConceptScore W4387338268C164705383 @default.
- W4387338268 hasConceptScore W4387338268C207103383 @default.
- W4387338268 hasConceptScore W4387338268C2778198053 @default.
- W4387338268 hasConceptScore W4387338268C2778213512 @default.
- W4387338268 hasConceptScore W4387338268C2779161974 @default.
- W4387338268 hasConceptScore W4387338268C2780007028 @default.
- W4387338268 hasConceptScore W4387338268C2781414266 @default.
- W4387338268 hasConceptScore W4387338268C44249647 @default.
- W4387338268 hasConceptScore W4387338268C50382708 @default.
- W4387338268 hasConceptScore W4387338268C555293320 @default.
- W4387338268 hasConceptScore W4387338268C71924100 @default.
- W4387338268 hasConceptScore W4387338268C72563966 @default.
- W4387338268 hasConceptScore W4387338268C78085059 @default.
- W4387338268 hasIssue "10" @default.
- W4387338268 hasLocation W43873382681 @default.
- W4387338268 hasOpenAccess W4387338268 @default.
- W4387338268 hasPrimaryLocation W43873382681 @default.
- W4387338268 hasRelatedWork W2091139515 @default.
- W4387338268 hasRelatedWork W2104371670 @default.
- W4387338268 hasRelatedWork W2355594703 @default.
- W4387338268 hasRelatedWork W2779222010 @default.
- W4387338268 hasRelatedWork W2920644863 @default.
- W4387338268 hasRelatedWork W2964563167 @default.
- W4387338268 hasRelatedWork W3029306217 @default.
- W4387338268 hasRelatedWork W3033076790 @default.
- W4387338268 hasRelatedWork W4206264227 @default.
- W4387338268 hasRelatedWork W4382048704 @default.
- W4387338268 hasVolume "39" @default.
- W4387338268 isParatext "false" @default.
- W4387338268 isRetracted "false" @default.
- W4387338268 workType "article" @default.